TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Still a Risk or on the Way up?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could experience amazing growth, but with all that debt, it remains incredibly risky.

    Read more »

    The Motley Fool
    Investing

    Danger: 3 Types of Stocks to Avoid in a Rising Interest Rate Environment

    Who controls interest rates? And why would it be dangerous to invest in stocks like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX)…

    Read more »

    The Motley Fool
    Investing

    How Rising Rates May Bankrupt Valeant Pharmaceuticals Intl Inc.

    With higher rates leading to higher interest costs, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are on their way down.

    Read more »

    The Motley Fool
    Investing

    Long-Term Investors: Buy the Dip With Valeant Pharmaceuticals Intl Inc.

    Where are shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) headed after extreme volatility of late?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical Intl Inc. Is Back on the Growth Track: Time to Buy?

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) suffered a massive 9.57% plunge following a huge +10% post-earnings rally. Should investors buy as…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc.’s Stock Is Soaring Over 10%

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is up 10%. Should you be buying or selling?

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Dropping Is of Little Consequence

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) dropped nearly 10% in the past week, but the stock is becoming an intriguing turnaround…

    Read more »

    Investing

    Which Should You Buy: Valeant Pharmaceuticals Intl Inc. or Home Capital Group Inc.?

    Home Capital Group Inc. (TSX:HCG) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have seen their stock prices fall this year. Can either…

    Read more »

    Dividend Stocks

    Will Negative-Beta Stocks Help Outperform the TSX?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen returns of over 4% year to date, while the TSX has seen losses.

    Read more »

    The Motley Fool
    Investing

    Could Valeant Pharmaceutical Intl Inc. Hit $30?

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) appears to be turning a corner. Could a huge rally be on the horizon?

    Read more »

    The Motley Fool
    Top TSX Stocks

    Top Stocks for August

    Top stocks for August include Fairfax Financial Holdings Ltd. (TSX:FFH) and Baytex Energy Corp (TSX:BTE)(NYSE:BTE).

    Read more »

    The Motley Fool
    Dividend Stocks

    These 2 Stocks Are Ridiculously Cheap

    Bargain-hunters take note: Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) went “from the outhouse to the penthouse, and back to the outhouse…

    Read more »